Featured image
Biotechnology Companies

Storm Therapeutics

Storm Therapeutics is a biotechnology company based in Cambridge, England. They specialize in the development of therapies that target RNA-modifying enzymes for the treatment of cancer and other diseases. In addition to their biotechnology focus, Storm Therapeutics also has expertise in IT and e-commerce.

Introduction to Storm Therapeutics

Storm Therapeutics is a biotechnology company that was founded in 2015 in Cambridge, England. The company's purpose is to develop small molecule therapies that target RNA-modifying enzymes. They are focused on developing drugs to treat cancer and other diseases. What makes this company unique is their technology platform, which enables the discovery of new medicines that target RNA, an area previously considered "undruggable."

Services & Products

Storm Therapeutics offers drug discovery services, focusing on RNA modifying enzymes as targets for small molecule drugs. They have developed a proprietary platform that allows them to identify and develop new treatments for cancer and other diseases.

Location

Storm Therapeutics is located at Babraham Hall House in Babraham, Cambridge. The area is known for its scientific research and is home to many biotechnology companies. The closest public transportation options are the Babraham Park and Ride, the Cambridge Biomedical Campus Bus Stop, and the Great Abington, High Street Bus Stop, all within a 2-mile radius.

Benefits

Customers should choose Storm Therapeutics because they are a leader in the field of RNA-modifying enzymes. Their technology platform allows them to discover new treatments for cancer and other diseases, an area that was previously thought to be "undruggable." They are committed to developing innovative therapies that have the potential to transform patient care.

Good to Know

Customers should be aware that Storm Therapeutics is a biotechnology company focused on drug discovery, not a direct-to-consumer company. They do not sell products directly to patients.

Reviews

Customers have praised Storm Therapeutics for their innovative approach to drug discovery and their commitment to developing new treatments for cancer and other diseases. They are seen as leaders in the field of RNA-modifying enzymes, and their technology platform is highly regarded.

Amenities

  • amenity
    lab equipment
  • amenity
    research facility
  • amenity
    conference room
  • amenity
    data analysis
  • amenity
    bioinformatics

FAQ

What specific areas of biotechnology does your company specialize in?

We specialize in RNA-modifying enzymes and their role in gene expression and disease. Our focus is on developing small molecule therapies that target these enzymes.

Can you provide examples of successful biotech projects your company has completed?

We are currently in the pre-clinical stage with our lead program, which targets a specific RNA-modifying enzyme implicated in cancer. We have also developed a unique platform technology for discovering and developing small molecule therapies targeting RNA-modifying enzymes.

What kind of expertise and experience do your employees have in biotechnology?

Our team consists of experts in RNA biology, enzymology, medicinal chemistry, and drug development. Many of our employees have years of experience in the biotech industry and have contributed to the development of successful drugs.

How does your company ensure regulatory compliance in biotech research and development?

We have a dedicated team that ensures compliance with all relevant regulations and guidelines, including those from the FDA and EMA. We also work closely with regulatory agencies throughout the drug development process to ensure that our programs meet all requirements.

What measures does your company take to protect intellectual property in the biotech industry?

We have a robust intellectual property portfolio that includes patents covering our platform technology and lead programs. We also work with experienced patent attorneys to ensure that our intellectual property is protected in all relevant jurisdictions.